Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
Neurology. 2021 Dec 2;98(4):e376-89. doi: 10.1212/WNL.0000000000013121. Online ahead of print.
Neurology. 2021.
PMID: 34857535